CSIMarket
 
Foxo Technologies Inc   (FOXO)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Foxo Technologies Inc's Customers Performance

FOXO



 
FOXO's Source of Revenues During the corresponding time, Foxo Technologies Inc saw a revenue deteriorated by -34.46 % year on year, sequentially revenue fell by -38.78 %. While revenue at the Foxo Technologies Inc 's corporate clients

List of FOXO Customers




for the same period Foxo Technologies Inc revnue deteriorated by -34.46 % year on year, sequentially revenue fell by -38.78 %.

List of FOXO Customers

Foxo Technologies Inc's Business Units
Corporate and Other Segment    0.3 % of total Revenue
Health Cares    196.59 % of total Revenue
Life Science Services    12.73 % of total Revenue
Member    209.61 % of total Revenue






Foxo Technologies Inc's Comment on Sales, Marketing and Customers



Vector obtains human biological specimens from third-party clinical institutions and specimen providers responsible for ethical sourcing and donor consent. The company offers biological specimens and epigenetic biomarker analysis services through a distributed testing model that includes FOXO Labs for data analysis and partner wet labs for laboratory testing. Vector serves healthcare providers, clinical laboratories, and transportation networks involved in specimen delivery. Its laboratory testing operations comply with federal and state regulations, including the Clinical Laboratory Improvement Amendments (CLIA) and the Federal Food, Drug, and Cosmetic Act (FDC Act). Vector's epigenetic testing services are intended for general health, wellness, and non-diagnostic purposes.





Foxo Technologies Inc’s Comment on Sales, Marketing and Customers


Vector obtains human biological specimens from third-party clinical institutions and specimen providers responsible for ethical sourcing and donor consent. The company offers biological specimens and epigenetic biomarker analysis services through a distributed testing model that includes FOXO Labs for data analysis and partner wet labs for laboratory testing. Vector serves healthcare providers, clinical laboratories, and transportation networks involved in specimen delivery. Its laboratory testing operations comply with federal and state regulations, including the Clinical Laboratory Improvement Amendments (CLIA) and the Federal Food, Drug, and Cosmetic Act (FDC Act). Vector's epigenetic testing services are intended for general health, wellness, and non-diagnostic purposes.








FOXO's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Foxo Technologies Inc 0.00 27.32 -13.28 192
SUBTOTAL 0.00 0.00 0.00 -

Sources: Foxo Technologies Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Foxo Technologies Inc’s corporate clients.
For your research, we’ve provided 9 tables on Foxo Technologies Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.